NBTY sales over $500 mil. forecast for fiscal year; sales up 131% to $109.4 mil. in quarter.
This article was originally published in The Tan Sheet
Executive Summary
NBTY STRATEGIC TARGET IS OVER $500 MIL. IN ANNUAL SALES in fiscal 1998 (ending Sept. 30), Bohemia, N.Y.-based NBTY declared Jan. 23. The projected sales figure would put the company on pace for an increase in revenues of more than 78% based on FY 1997 consolidated sales of $281.4 mil. ("The Tan Sheet" Nov. 17, 1997, p. 28). Sales in FY 1997 were up 45% from the previous year.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: